FDA clocks record number of recalls

Share this article:

The FDA is setting a record. Regulatory Focus reports that the regulator has issued more recalls since the beginning of 2013 than it did over the previous nine years. RF says the record-breaking streak is punctuated by a spike in Class-II recalls, which means drugmakers pulled items which may cause “temporary or medically reversible adverse events.”

RF says Class-II recalls have become a mainstay of total recall numbers for a while, and that the uptick is linked to compounding pharmacies which have undergone increased scrutiny since the 2012 fungal meningitis outbreak that killed more than 60 patients.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs


Reimagining healthcare? We want to hear about it.
 
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters

MM&M inVISION

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.